All In MedTech

FDA Clearance Tracker · P990033

PEPGEN P-15

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Oct 25, 1999 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

The decision

FDA number
P990033
Device name
PEPGEN P-15
Applicant
Ceramed Corp.
Applicant location
Lakewood, CO
Received
Jun 24, 1999
Decided
Oct 25, 1999
Decision
Approval withdrawn
Supplements
11 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 872.3930

Every decision under product code NPZ

FDA's approval statement

As written in FDA's record.

Approval for PepGen P-15. This device is intended to be used for intrabony periodontal osseous defects due to moderate or severe peridontitis.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code NPZ (Bone grafting material, dental, with biologic component).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Ceramed Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.